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Abstract: Genistein, daidzein, glycitein and quercetin are flavonoids present in soybean 
and other vegetables in high amounts. These flavonoids can be metabolically converted to 
more active forms, which may react with guanine in the DNA to form complexes and can 
lead to DNA depurination. We assumed two ultimate carcinogen forms of each of these 
flavonoids, diol epoxide form and diketone form. Density functional theory (DFT) and 
Hartree-Fock (HF) methods were used to study the reaction thermodynamics between active 
forms of flavonoids and DNA guanine. Solvent reaction field method of Tomasi and   
co-workers and the Langevin dipoles method of Florian and Warshel were used to calculate 
the hydration free energies. Activation free energy for each reaction was estimated using the 
linear free energy relation. Our calculations show that diol epoxide forms of flavonoids are 
more reactive than the corresponding diketone forms and are hence more likely flavonoid 
ultimate carcinogens. Genistein, daidzein and glycitein show comparable reactivity while 
quercetin is less reactive toward DNA. 
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1. Introduction  
Carcinogenesis is a complex pathological process, where normal cells become neoplastic. It is 
mainly the process associated with chemical modification of DNA. Chemical modification of DNA 
could be caused by viruses, photochemical reactions or reactive substances, called carcinogens [1–4]. 
Carcinogens can either be of endogenous origin [5,6] (i.e., hormones or their metabolites) or of 
exogenous origin [7] (i.e., those chemicals that originate from the environment). The first step   
for chemically induced carcinogenicity is the alteration of the cellular DNA by the reactive form of 
carcinogen. Failure to repair DNA adducts can lead to depurination, as in the case of polyaromatic 
hydrocarbons [8], or to errors in DNA replication. Both introduce a mutation in DNA which can cause 
translocation and amplification of specific genes (proto-oncogenes), which translate into transformation 
from normal to altered cell. Indeed, multiple cumulative mutational events are invariably required for the 
progression from normal to fully malignant phenotype [9]. The altered cell may remain dormant or under 
specific circumstances may proliferate into paraneoplastic and ultimately progress to neoplastic cell. It 
is clear that repair mechanisms and the immune system play very important roles in carcinogenesis. 
The repair mechanisms in cells are very proficient, but there is evidence that they can be overwhelmed 
and consequently fail as well. For a recent review see [10].  
Genistein, daidzein, glycitein and quercetin are flavonoids present in soybean [11] and other vegetables 
in high amounts, while quercetin is also sold as a dietary supplement. The majority of publications have 
focused on the inhibition effect of flavonoids on cell proliferation, although, experiments on the oral 
squamous cell line SCC-25 have shown a biphasic effect of quercetin on cell proliferation [12]. It  
was found that quercetin stimulated cell proliferation at concentrations up to 10 μM, whereas at higher 
concentrations, cell proliferation was inhibited and it is unclear under what conditions either of the 
effects prevail. Dihal and his group, has shown the ability of quercetin to inhibit the differentiation of 
Caco-2 cells in a behavior opposite to the anti-carcinogenic adducts with cellular protein and DNA in 
which, under certain conditions, cancer incidences are increased in experimental animals [13–19]. Some 
of these flavonoids exhibit estrogenic activity [20–22], but they are usually used for their powerful 
antioxidant [23] and chemopreventive properties [24–26]; their bioactivated forms are to a certain extent 
capable of reacting with DNA. Similar to polyaromatic hydrocarbons (PAHs), which are known 
carcinogens [27,28], flavonoids are not carcinogenic per se, but can become carcinogenic after 
bioactivation. The unmetabolized form is called procarcinogen, while the bioactivated metabolized form 
is called the ultimate carcinogen. PAHs [29,30], estrogens [31] and flavonoids are all metabolized by the 
family of cytochromes P450 to a wide variety of primary metabolites, including epoxides, dihydrodiols, 
quinones, and phenols [32–34], many of which can be reoxidized and recycled through the same 
metabolic pathways [29,30,35,36] giving rise to metabolites that are able to chemically react with 
DNA [27,30,37]. Studies on PAHs and estrogens have led us to conclude that the ultimate carcinogens 
of studied polyphenols can be either of diol epoxide or quinone type. This assumption is strengthened by 
studies that showed that the formation of quercetin’s quinone type metabolites is fast. The oxidations are Int. J. Mol. Sci. 2012, 13                 
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performed by peroxidases (one electron oxidation) to form quercetin semiquinone radical and by 
tyrosinases (two electron oxidation) to form quercetin o-quinone [38,39].  
The reaction responsible for the initial phase of carcinogenesis is alkylation of DNA by an ultimate 
carcinogen, typically at position N7 of guanine, although other alkylation sites are also possible [5]. It is 
well established, that guanine at position N7 is the most nucleophilic site of DNA and hence most likely 
to react [40]. Moreover, it was proven experimentally that large majority of the DNA chemical damages 
are associated with this site. Currently, quantum chemical calculations cannot treat the entire solvated 
DNA plus the ultimate carcinogen molecule into electronic details. Therefore we truncated the system 
to methylated guanine and the ultimate carcinogen, while the rest of the system was treated on the 
level of mean field theory on the Langevin dipoles and solvent reaction field levels. The approach 
proved to be successful and became a standard way of computational treatment for a large number of 
systems of biological interest. This approach represents an acceptable trade-off between physical 
relevance of the model and computational feasibility. 
One strategy of preventing chemical damages of DNA is introduction of substances that react   
with the ultimate carcinogen faster than the ultimate carcinogen reacts with DNA [41]. Ascorbic acid 
and glutathione are well-known endogenous scavengers of ultimate carcinogens. The increased 
incidence of prostate cancer induced by complexation of glutathione by heavy metals is well 
documented in clinical practice [9]. Ellagic acid and polyphenols, such as flavonoids considered in  
this study, are also typically very efficient scavengers, but their bioactivated diol epoxide or quinone 
forms are nevertheless able to react with DNA. Thus it is not surprising that there have been studies 
concerning the safety of quercetin [42–45]. While many long-term studies showed that this compound 
is not carcinogenic [46,47] there are also contradicting results [48,49]. Moreover, it has been shown 
experimentally that genistein can mediate DNA strand breaks by H2O2/Cu(II) thus exerting influence 
on oxidative DNA damage [50]. It is worth to give comment on the accessibility of the DNA to the 
ultimate carcinogens. The ultimate carcinogens have no problems to reach densely packed genetic 
material. Biological macromolecules are soft and flexible and transport of the substrate to the reactive 
site is never the rate-limiting step. 
The aim of this study was to critically examine the reactivity toward N7 position of guanine of four 
flavonoids and, for each of them, the both reactive forms were considered. Calculations were 
performed on Hartree-Fock and DFT level in conjunction with 6-31G(d) basis set. This double zeta 
basis set augmented with polarization functions on heavy atoms, is flexible enough to reliably describe 
the thermochemistry of the studied reactions. We considered the density functional B3LYP, where 
electron exchange is described by the method of Becke [51–53] and electron correlation by the 
methodology of Lee, Yang and Parr [54]. Structures were first optimized at the PM3 semiempirical MO, 
followed by HF and B3LYP calculations. Geometry optimizations were performed in the gas phase. 
For the reactive step we considered linear free energy relationship since the rate-limiting step involves 
proton transfer via solvent and locating the corresponding transition state is unfeasible. The effects of 
solvation were included by using solvent reaction field method of Tomasi and coworkers [55] and 
Langevin dipoles method of Florian and Warshel [56,57]. Int. J. Mol. Sci. 2012, 13                 
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2. Results and Discussion  
In this article, we considered two mechanisms for the DNA-adduct formation reaction according to 
the active form of the flavonoids. Since the selected flavonoids are structurally closely related, the linear 
free energy relation method was selected for our study. Moreover, the studied reactions are electrophilic 
substitutions with a complex mechanism involving proton transfer via several solvent molecules. Hence, 
locating the transition state and calculating the activation free energy for such a complex reaction is not 
practical. The application of linear free energy relationships to estimate the free energy of activation is 
well established and is described in reference [58]. In a series of chemical reactions involving similar 
reactants, which follow the same mechanism, the reaction with the most favorable reaction free energy 
will have the lowest free energy of activation. Detailed information on the two different proposed 
mechanisms and the type of adducts formed with guanine, as a model for DNA, using HF and DFT 
calculations, the chemical reaction will be discussed below. 
2.1. Diol Epoxide Mechanism  
The covalent binding of reactive intermediates to cellular DNA leading to adduct formation is 
considered to be a critical event in the initiation of carcinogenesis. Flavonoids may interfere with this 
process, by blocking the formation of reactive intermediates which can potentially prevent the initiation 
of carcinogenesis inhibiting the metabolic activation of the carcinogen to its reactive intermediates [59]. 
The effects of flavonoids on procarcinogen-activating enzymes, notably the cytochrome P450 CYP1 
family, have been the focus of attention in cancer prevention during the last decade. For flavonoids to 
bind to DNA, these chemicals need bioactivation to a more reactive diol epoxide form that later attacks 
the N7 site of the DNA guanine to form DNA-adduct by enzymes such as cytochrome P450 (CYP) and 
epoxide hydrolase (EH) [60–62]. 
According to the diol epoxide mechanism the reaction proceeds in the following possible pathway. 
The N7 site of the DNA guanine approaches the epoxy ring carbon atom. During the reaction the 
strained epoxy ring opens, and formation of the chemical bond between the epoxy ring carbon atom 
and guanine is the rate-limiting step, followed by a fast proton transfer involving solvent molecules. 
In this reaction, stereoisomeric epoxide reactant gives stereoisomeric product. These are soft 
degrees of freedom and the energy difference of several conformations is not large (<1 kcal/mol) and it 
is often difficult to decide simply by inspection which conformation will be adopted. Therefore, we 
have considered only one stereoisomer for comparison as shown in Scheme 1 for the entire calculation 
series. Besides, from previous linear free energy relationship study of benzo[a]pyrene diol epoxide 
stereoisomers [63], different conformations do not have much effect on reactivity.  Int. J. Mol. Sci. 2012, 13                 
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Scheme 1. The diol epoxide mechanism for the DNA-adduct formation. 
 
The calculated reaction energy (ΔE), zero point energy correction (ZPE) and the reaction free 
energy for the flavonoids are listed in Table 1. The calculated reaction free energy for the chemical 
reaction calculated as the difference in energy between the reactants (flavonoids + guanine) and   
the product, which is the flavonoid-guanine complex (DNA adduct) from PCM was found to be lower 
than LD using both DFT and HF calculation for diol epoxide mechanism. The slightly lower values 
obtained from HF were found to be −27.98 (quercetin), −27.77 (genistein), −27.32 (daidzein), and 
−26.91 (glycitein) kcal/mol in similar trend agreed with DFT method among the calculated flavonoids. 
The negative sign indicates that the reaction is energetically favored. These values include the   
HF/6-31G(d) calculated classical barrier, 2.40–2.58 kcal/mol of calculated zero point energy correction 
and 1.48–2.23 kcal/mol of difference in free energy of hydration calculated using Tomasi’s approach. 
In comparison, the Langevin dipoles method for hydration free energy difference gave a value of 
13.90–18.60 kcal/mol. It is clear that there is no significant difference between reaction free energies 
for the reactions of all active flavonoids with guanine. Neither in vacuo values of energies differ from 
each other nor the contributions from hydration free energies for both methods of calculation with the 
PCM solvent reaction field or the Langevin dipoles method.  
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Table 1. Free energy components for reactions via diol epoxide and diketone mechanism 
with density functional theory (DFT) and Hartree-Fock (HF) calculation. 
DFT Method (B3LYP/6-31G(d)) 
  ΔE 
a  ΔZPE 
b 
PCM method   LD method  
ΔGhydr 
c  ΔGreact 
d  ΔGhydr  ΔGreact 
Diol epoxide mechanism  
Genistein  −30.04 2.19 1.34  −26.51 6.50  −21.35 
Daidzein  −29.74 2.21 1.20  −26.33 5.80  −21.73 
Glycitein  −29.66 2.24 1.85  −25.57 5.90  −21.52 
Quercetin  −31.95 2.55 1.52  −27.88 11.10  −18.30 
Diketone mechanism 
Genistein  −26.83 3.73  11.31 −11.79 5.82  −17.28 
Daidzein  −22.79 3.50 7.85  −11.44 3.28  −16.01 
Glycitein  −22.94 3.50 7.65  −11.79 1.32  −18.12 
Quercetin  −20.44 1.84 0.42  −18.18 12.40  −6.20 
HF Method (HF/6-31G(d)) 
  ΔE 
a  ΔZPE 
b 
PCM method   LD method  
ΔGhydr 
c  ΔGreact 
d  ΔGhydr  ΔGreact 
Diol epoxide mechanism  
Genistein  −31.68 2.43 1.48  −27.77 18.60 −10.65 
Daidzein  −31.26 2.40 1.54  −27.32 17.00 −11.86 
Glycitein  −31.16 2.40 1.85  −26.91 15.10 −13.66 
Quercetin  −32.79 2.58 2.23  −27.98 13.90 −16.31 
Diketone mechanism 
Genistein  −23.30 1.57 1.39  −20.34 23.30  1.57 
Daidzein  −17.58 1.59 0.93  −15.06 17.70  1.71 
Glycitein  −17.49 1.60 1.06  −14.83 21.70  5.81 
Quercetin  −14.45 1.52 1.06  −11.87 14.50  1.57 
a Energy difference between the reactants (flavonoids + guanine) energy and the product which is 
the flavonoid-guanine complex (DNA adduct) in the gas phase based on B3LYP/6-31G(d); 
b Zero 
point energy (ZPE) corrections; 
c ΔGhydr, free energy of hydration differences; 
d ΔGreact, reaction 
free energy, ΔGreact = ΔE + ΔZPE + ΔGhydr. All energies are in kcal/mol. 
Experimental and theoretical results show that the polyaromatic hydrocarbons diol epoxide form  
is biologically active in the Fjord and Bay region and this activity is attributed to the high affinity  
for protonation and the high thermodynamic stability of the resulting cation [30,50]. According to  
our calculations, the diol epoxide forms of the flavonoids are highly active for attack on DNA,   
which may be attributed to the presence of the epoxide group. Figure 1 shows the geometry of the 
flavonoid-guanine complex according to the diol epoxide mechanism in which the guanine molecule 
has a nearly perpendicular position to the plane of the flavonoid molecule.  Int. J. Mol. Sci. 2012, 13                 
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Figure 1. DFT optimized structures of the complex of the flavonoids diol   
epoxide-N7-guanine for (a) genistein-guanine, (b) daidzein-guanine, (c) glycitein-guanine, 
and (d) quercetin-guanine. 
(a) (b) (c) (d) 
2.2. Diketone Mechanism 
The active form of the flavonoids in this reaction mechanism is in the diketone form and the reaction 
proceeds as in Scheme 2. The N7 site of the DNA guanine approaches the diene ring carbon atom, which 
is followed by the reduction of diketone to form the hydroxyl group. The calculated reaction free energy 
for the chemical reaction for DFT and HF are quite different. As a result in general, three isoflavones 
have a lower reaction free energy or the lower activation energy barrier in comparison to quercetin 
from diketone mechanism. However, with LD method using HF calculation, the diketone mechanism 
of all flavonoids is not favorable with positive reaction free energy. Also, quercetin appears with the 
most negative reaction free energy (−18.18 kcal/mol) on DFT with PCM solvation model. Calculations 
of hydration free energy on the HF/6-31g(d) level of theory exaggerates with the dipole moment and  
it corresponds to the polarized case as is the situation in aqueous solution. Langevine dipoles model 
was also parametrized for this level and hydration free energies are quite reliable. B3LYP functional 
systematically underestimates the reaction barrier due to absence of parametrization set for diketone 
species in the calculation as it is observed in PCM model for isoflavones with   
−11.44 to −11.79 kcal/mol (DFT) and −14.83 to −20.34 kcal/mol (HF).  These values in   
B3LYP/6-31G(d) level also include the calculated classical barrier, 1.84–3.73 kcal/mol of   
B3LYP/6-31G(d) calculated zero point energy correction and 1.32–12.40 kcal/mol of difference in free 
energy of hydration calculated using the Langevin dipoles method as implemented in program 
ChemSol 2.1. In comparison, Tomasi’s approach for hydration free energy difference gave a value of 
0.42–11.31 kcal/mol. It is also clear that there is no significant difference between reaction free 
energies for the reactions of all active flavonoids with guanine under this mechanism either in vacuo or 
with solvation contribution. Int. J. Mol. Sci. 2012, 13                 
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Scheme 2. The diketone mechanism for the DNA-adducts formation. 
 
 
According to the values of the reaction energy and the reaction free energy diketone metabolites are 
less reactive than the diol epoxide. The diol epoxide mechanism shows no activity difference among 
flavonoids either in gas or solvent calculation. The calculated zero point contributions to reaction free 
energies for the three isoflavones are essentially identical, whereas a slightly higher value found for 
quercetin,  as  free energy of hydration was modeled on two levels of theory, PCM and LD.   
As parametrization of the Langevin dipole (LD) model is developed for quantum calculations of 
chemical processes in aqueous solution, the extension of the model to other polar solvents would 
require some simple reparameterization. The implementation and parametrization for aqueous solution 
was described with the training set that encompassed solvation free energies of 44 neutral and 39 ionic 
solutes of the C, O, N, P, S, F, and Cl atoms and was found to be comparable or slightly better than the 
PCM continuum model of Tomasi and co-workers to predict the acid dissociation constants (pKa) of 
the chemicals involved in proton transfer. Simplified explicit representation of solvent molecules of 
the LD model gives better insight into the molecular origin of different solvent effects than that 
obtained by continuum models. Solvent in LD model is approximated by polarizable discrete dipoles 
fixed on a cubic grid whereas the Polarizable Continuum Model calculates the molecular free energy in 
solution as the sum over the electrostatic, the dispersion-repulsion contributions to the free energy, and 
the cavitation using a cavity defined through interlocking van der Waals spheres centered at atomic 
positions. The three flavonoids (genistein, glycitein, and daidzein) according to the first mechanism show 
no substantial difference in hydration free energy. Interestingly, we noticed that quercetin according to 
both mechanisms on DFT with LD method needed more energy for hydration in comparison with 
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genistein, glycitein, and daidzein. This behavior can be attributed to the extra hydroxyl group with 
higher polarization and electron correlation effect. The comparison of the values of the total energy in 
the gas phase by using HF and DFT theory and the values of the reaction free energy between the two 
mechanisms clearly showed that the first mechanism gives better results. 
Figure 2. DFT optimized structures of the diketone flavonoid-N7-guanine complexes for  
(a) genistein-guanine, (b) daidzein-guanine, (c) glycitein-guanine, and (d) quercetin-guanine. 
  
(a) (b) (c) (d) 
Comparing the two different calculation methods from Table 1, we achieved similar barrier heights 
in gas phase in diol epoxide mechanism, 29.66–31.95 kcal/mole for DFT and 31.16–32.79 kcal/mol  
for HF, however, application of HF significantly reduced the barrier (14.45–23.30 kcal/mol) in 
diketone mechanism. In previous work on alkylation of guanine by styrene-7,8-oxide, the combination 
of Hartree-Fock calculation using flexible basis sets and Langevin dipoles calculation of hydration free 
energies gives very reasonable agreement with the experimental free energy (26.52 kcal/mol) whereas 
B3LYP calculations predict a lower activation free energy [64]. We have the impression that the applied 
DFT method outperforms the HF calculations. Strong evidence indicates that for diketone mechanism, 
with hydration contributions included, the free energies are positive. The DFT calculated reaction free 
energies are lower for epoxide mechanism than for diketone mechanism for all the species. Therefore 
it is very likely, that the carcinogenic reaction proceeds via epoxide mechanism unless flavonoids 
activation by P450 is the rate-limiting step. Our calculations give strong evidence that genistein, daidzein 
and glycitein are basically equally reactive toward DNA, while quercetin has different reactivity, less 
reactive on DFT or more reactive on HF with LD solvation model. This is a possible reason why 
isoflavones may interfere with the promotion stage of carcinogenesis by blocking the formation of the 
metabolic activation of the carcinogen to its reactive intermediates. Thus, it remains a major challenge 
to fine tune the reactivity of quercetin analogs to widen the therapeutic window. 
Finally, we can conclude that chemical reactions for four selected flavonoids either with diol 
epoxide or diketone for this, since free reaction energies are quite similar for all four flavonoid diol 
epoxides. One possible explanation is that different metabolic transformations at different rates may be 
the source of discrepancies in carcinogenicity. Other metabolic transformations at different rates could be 
found in particular reactions catalyzed by enzymes such as catechol-O-methyl transferase (COMT), 
glutathione-S-transferase, P450 (CYP families), aromatase and various peroxidases [63,65]. In addition, 
different reaction rates may occur in DNA depurination step, which would also result in different 
carcinogenicity profiles of studied compounds. Moreover, not only DNA, but proteins, as well as cellular 
lipids and some metallic ions (iron and copper) are targets for reactions with quinines [66,67]. It is Int. J. Mol. Sci. 2012, 13                 
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therefore clear that reaction rates of metabolic transformations, adduct formation, depurination and 
reactivity with other cellular components all contribute to the overall carcinogenicity of studied 
compounds. The molecular modeling of chemical reactivity of each of these steps will play an 
important role in cancer research and will ultimately contribute to the prevention and improvement of 
cancer treatment. 
3. Computational Detail 
Initial structures of the flavonoids and the flavonoid-guanine adducts were built using Molden 
program. PM3 semiempirical MO method was used to refine the starting structures, which were 
submitted to the HF and DFT optimization with 6-31G(d) basis set. No constraints were applied. The 
double-zeta basis set augmented with polarization functions on heavy atoms is flexible enough to 
describe chemical processes and is also computationally tractable. To ensure that the optimized 
structure is the real minima rather than saddle points, vibrational analysis was performed in the 
harmonic approximation and the absence of imaginary frequencies proves that the stationary points are 
real minima rather that the saddle points. To consider the solvent effect on the reaction mechanism, the 
polarizable continuum model of Tomasi and coworkers as implemented in Gaussian03 was applied. 
Moreover, Langevin dipoles (LD) method in which the solute is described by a set of point charges  
on the grid of the Langevin dipoles, together with a proper parameterization, has received attention 
during the past years to model solvation effects. Langevin dipoles calculations were performed using 
CHEMSOL versions 2.1 package kindly provided by Jan Florian. The Merz-Kollman charges were 
calculated at B3LYP/6-31G(d) level using Tomasi’s PCM SCRF. 
The reaction free energy was calculated as the free energy difference between products and the 
reactants corrected for zero point energy contribution calculated in the harmonic approximation and 
the hydration free energy.  
ΔGreact = ΔE + ΔZPE + ΔGhydr 
Langevin dipoles and Gaussian03 [68] calculations were performed on a dual-CPU PC/Linux cluster. 
4. Conclusions  
Reaction free energy and the free energy of hydration were calculated for four flavonoids present  
in soybean: genistein, daidzein, glycitein, and quercetin, for their reaction with guanine according to 
two kinds of mechanisms; diol epoxide and diketone mechanism. HF and DFT levels of theory in 
conjunction with 6-31G(d) basis set were employed for calculating the reaction energies in vacuo. LD 
and PCM solvation models were used for calculation of hydration free energies thus enabling the 
calculation of reaction free energies. This work sheds light on the mechanism of action of flavonoids. 
The results show that the diol epoxide mechanism describes the carcinogenic reaction better than  
the diketone mechanism. Our study shows that metabolites of soy food products are slightly reactive 
toward DNA but flavonoids are even more reactive toward the ultimate carcinogens of the epoxy  
type. In terms of cancer prevention, it is still beneficial to consume soy products. Quantum chemical 
calculations are valuable for the design of flavonoids derivatives with even lower activation energy 
and increased reactivity toward ultimate carcinogens as well as controlled reactivity toward DNA. Int. J. Mol. Sci. 2012, 13                 
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